- 2012
-
What's on? - 14.12.2012
(French) La présence de sels d’aluminium dans les vaccins constitue-t-elle un danger?
The aluminium salts used in the makeup of vaccines could have adverse effects on health. The metal could build up in the central nervous system and cause a rare disease known as macrophagic myofasciitis that can cause intense muscular pain, cognitive disorders and intense fatigue, among other symptoms. Romain Gherardi, Inserm researcher at the Inserm […]
-
News in brief - 12.12.2012
The carrot or the stick?
Although they did not answer this question directly, the INSERM researchers under Mathias Pessiglione at the Neuroscience Research Centre of the Pitié Salpêtrière Hospital recently showed that very specific regions are activated in the brain when faced with either situation. Certain regions of the brain (the anterior insula and the dorsal striatum) constitute a system […]
-
Press releases - 11.12.2012
A promising clinical trial to reduce the severity of autistic disorders
Yehezkel Ben-Ari, Founder and Honorary Director of INMED (Institut de Neurobiologie de la Méditerranée), INSERM, and Eric Lemonnier, a clinician specialising in autism at the CHRU of Brest, recently published the results of a double-blind clinical trial to evaluate the usefulness of a diuretic in the treatment of autism
-
Press releases - 10.12.2012
Adipocyte inflammatoire de l’obèse : une cellule en perte de contrôle
Une étude menée chez des sujets obèses par Nicolas Venteclef, chargé de recherche Inserm et Pr Karine Clément (Equipe « Nutrition et obésité : approche génétique et transcriptomique », Centre des Cordeliers Inserm, Université Pierre et Marie Curie , Institut de Cardio-métabolisme et Nutrition, Paris) en collaboration avec une équipe du Karolinska Institutet en Suède, vient de mettre en évidence un mécanisme moléculaire contrôlant l’inflammation dans le tissu adipeux.
-
Press releases - 06.12.2012
Un diagnostic prénatal des maladies génétiques sur simple prise de sang
L’équipe de Patrizia Paterlini-Bréchot publie des résultats dans le diagnostic prénatal non invasif des maladies génétiques, avec comme exemple son application à l’amyotrophie spinale et à la mucoviscidose. Ce test sensible et spécifique à 100% sur un échantillon de 63 femmes est le premier à proposer une alternative à des méthodes dites invasives telles que l’amniocentèse et la biopsie de villosités choriales (BVC)
-
News in brief - 04.12.2012
The “still, small voice” in the brain has been found!
A collaborative effort between the INSERM researchers at the Lyon Centre de Recherche en Neurosciences and the Grenoble C.H.U. has just shown that our brains can react as if we were hearing someone talking to us even though no one else is in the room. The research has been published in The Journal of Neuroscience. […]
-
What's on? - 03.12.2012
The Telethon: to take place on 7 and 8 December 2012 with the help of Inserm researchers
“Oser vaincre” (Dare to win) is the slogan for the Telethon 2012 campaign that will start on December 7 and 8. Three million people in France are affected by 6,000 different rare diseases. These diseases, mostly genetic and disabling, had remained largely unknown for a long time. The aim of the Telethon is to put […]
-
Press releases - 03.12.2012
Improving chemotherapy effectiveness by acting on the immune system
An Inserm team in Dijon directed by François Ghiringhelli (Inserm unit 866 ‘Lipids, nutrition and cancer’) is to publish an article this week in the Nature Medicine review. The article suggests that two chemotherapy drugs frequently used to treat digestive and breast cancers may encourage the development of tumours by modulating the anti-tumoural immune response.
-
Press releases - 30.11.2012
November 30th 2012
Sorry, this article is only available in French.
-
What's on? - 30.11.2012
1 December: World AIDS Day
What research progress has been made? According to the WHO, 34 million people are currently infected by HIV. Only 1.3 million patients from poor countries have access to treatment and there are 6,800 new cases of HIV each day. The Human Immunodeficiency Virus (HIV) attacks the cells in the immune system, either destroying them or […]